TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

BHU scientist finds non-invasive method of cancer detection

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Varanasi, February 4

Advertisement

Dr Samrendra Kumar Singh, assistant professor, School of Biotechnology in the Institute of Science, Banaras Hindu University (BHU), has found a non-invasive method to diagnose cervical cancer in patients.

Advertisement

His findings have been published in the ‘Journal of Cancer Research and Therapeutics (JCRT)’.

The study finds a cost-effective and specific method for early detection, treatment monitoring, the status of residual disease and distant tumor metastasis in cervical cancer patients.

The study was undertaken in collaboration with the department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, BHU.

Advertisement

Singh said: “During the study, it was shown that circulating cell free DNA (ccf DNA) could be used as an effective marker to evaluate tumor burden in the patients, both in untreated and treated individuals. This study also shows that during concurrent chemo-radiotherapy, ccf DNA load disappeared and after six months of follow up, appeared back due to distant metastasis.” He said that the sensitivity and specificity of this method and short half-life of ccf DNA makes this method reliable and potent as an affordable and real-time biomarker for detecting tumor burden in cervical carcinoma patients.

The study has also shown a way to follow up prognostic outcomes of medication/surgery by using blood samples from cancer patients.

He said this study could be very useful in developing diagnostics for detection of cervical cancers which is one of the top killers of women worldwide.

The study was conducted on biopsy confirmed patients.

Currently the only way to diagnose cervical cancer among patients is via tissue biopsy, which is not only painful but also not available and accessible to everyone.

According to him, the study was conducted at one of the laboratories of the Institute of Science, BHU, which carries out research in the field of cancer, especially cervical cancer. For this purpose, the lab uses various molecular biology, biochemistry and structural biology tools.

IANS

Advertisement
Show comments
Advertisement